Mithoefer M

Department of Psychiatry and Behavioral Services, Medical University of South Carolina, Charleston, SC, United States.

6 papers · 1 preprint · ORCID

The conceptual framework for the therapeutic approach used in phase 3 trials of MDMA-assisted therapy for PTSD.

O'Donnell KC, Okano L, Alpert M +6

Author Correction: MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial.

Mitchell JM, Ot'alora G M, van der Kolk B +16

Effects of MDMA-assisted therapy for PTSD on self-experience.

van der Kolk BA, Wang JB, Yehuda R +7

ArticlePsilocybin

Group psychedelic therapy: empirical estimates of cost-savings and improved access.

Marseille E, Stauffer CS, Agrawal M +5

MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial.

Mitchell JM, Ot'alora G M, van der Kolk B +16

MDMA-Assisted Therapy for Severe PTSD: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study.

Mitchell JM, Bogenschutz M, Lilienstein A +35

Self-experience in MDMA assisted therapy of PTSD

van der Kolk BA, Wang JB, Yehuda R +7